DE60011924D1 - Ciclesonidhaltige wässrige arzneizusammensetzungen - Google Patents

Ciclesonidhaltige wässrige arzneizusammensetzungen

Info

Publication number
DE60011924D1
DE60011924D1 DE60011924T DE60011924T DE60011924D1 DE 60011924 D1 DE60011924 D1 DE 60011924D1 DE 60011924 T DE60011924 T DE 60011924T DE 60011924 T DE60011924 T DE 60011924T DE 60011924 D1 DE60011924 D1 DE 60011924D1
Authority
DE
Germany
Prior art keywords
medicamentic
ciclesonic
compositions
aqueous
medicamentic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60011924T
Other languages
English (en)
Other versions
DE60011924T2 (de
Inventor
Atsuhiro Nagano
Yoshihisa Nishibe
Kazuya Takanashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856339&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60011924(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Application granted granted Critical
Publication of DE60011924D1 publication Critical patent/DE60011924D1/de
Publication of DE60011924T2 publication Critical patent/DE60011924T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60011924T 1999-10-20 2000-10-20 Ciclesonidhaltige wässrige Arzneizusammensetzung Expired - Lifetime DE60011924T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29818699 1999-10-20
JP29818699 1999-10-20
PCT/JP2000/007351 WO2001028563A1 (en) 1999-10-20 2000-10-20 Ciclesonide-containing aqueous pharmaceutical composition

Publications (2)

Publication Number Publication Date
DE60011924D1 true DE60011924D1 (de) 2004-08-05
DE60011924T2 DE60011924T2 (de) 2005-07-07

Family

ID=17856339

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60011924T Expired - Lifetime DE60011924T2 (de) 1999-10-20 2000-10-20 Ciclesonidhaltige wässrige Arzneizusammensetzung

Country Status (36)

Country Link
US (2) US8383611B1 (de)
EP (1) EP1227817B1 (de)
JP (1) JP4856338B2 (de)
KR (1) KR100705372B1 (de)
CN (1) CN1198623C (de)
AR (1) AR026073A1 (de)
AT (1) ATE270107T1 (de)
AU (1) AU776587B2 (de)
BG (1) BG65799B1 (de)
BR (1) BRPI0014880B8 (de)
CA (1) CA2388325C (de)
CO (1) CO5251406A1 (de)
CZ (1) CZ297780B6 (de)
DE (1) DE60011924T2 (de)
DK (1) DK1227817T3 (de)
EA (1) EA005201B1 (de)
ES (1) ES2223595T3 (de)
HK (1) HK1051003A1 (de)
HR (1) HRP20020345B1 (de)
HU (1) HU228894B1 (de)
IL (2) IL148725A0 (de)
ME (1) ME00568B (de)
MX (1) MXPA02003975A (de)
MY (1) MY121175A (de)
NO (1) NO327379B1 (de)
NZ (1) NZ518299A (de)
PE (1) PE20010713A1 (de)
PL (1) PL197537B1 (de)
PT (1) PT1227817E (de)
RS (1) RS50345B (de)
SI (1) SI1227817T1 (de)
SK (1) SK286194B6 (de)
TR (1) TR200200831T2 (de)
TW (1) TWI269655B (de)
WO (1) WO2001028563A1 (de)
ZA (1) ZA200203078B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
CN100366256C (zh) * 2002-07-02 2008-02-06 奥坦纳医药公司 含有环索奈德的无菌水性混悬剂
DK1545548T3 (da) 2002-08-30 2010-09-27 Nycomed Gmbh Anvendelsen af kombinationen af ciclesonid og antihistaminer til behandingen af allergisk rhinitis
PL375819A1 (en) 2002-12-12 2005-12-12 Altana Pharma Ag Combination medicament
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20080008762A1 (en) * 2004-11-17 2008-01-10 Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services Steroid Formulation And Methods Of Treatment Using Same
JP5661985B2 (ja) 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
AU2009223649B2 (en) 2008-03-11 2013-08-29 Novartis Ag Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
US11007150B2 (en) 2011-08-18 2021-05-18 Covis Pharma Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
CH657779A5 (de) 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
AU572815B2 (en) 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
EP0163696B1 (de) 1983-11-14 1992-11-25 Columbia Laboratories, Inc. Verwendung eines bioadhesives
GB8515132D0 (en) 1985-06-14 1985-07-17 British Nuclear Fuels Plc Measuring photosynthetic activities of plants
US5179079A (en) 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
MY102411A (en) 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH0744940B2 (ja) 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
US4802967A (en) 1987-04-08 1989-02-07 Andus Corporation Surface treatment of polymers
JPS63303931A (ja) 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
US4788220A (en) 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
DE69014081T2 (de) 1989-10-31 1995-03-30 Columbia Lab Inc Mittel zur Feuchthaltung vaginalen Gewebes.
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
JPH078806B2 (ja) 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
GB9102579D0 (en) 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
AU668352B2 (en) 1991-04-03 1996-05-02 Keimowitz, Rudolph M.D. Suppression of thromboxane levels by percutaneous administration of aspirin
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
JP2860729B2 (ja) 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
CA2101126A1 (en) 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
JP3047948B2 (ja) 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5409703A (en) 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
JP2787131B2 (ja) 1993-07-30 1998-08-13 千寿製薬株式会社 水性懸濁液剤
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
JPH07188059A (ja) 1993-12-28 1995-07-25 Rohto Pharmaceut Co Ltd 歯周病治療剤
RU2102979C1 (ru) 1994-07-18 1998-01-27 Панкрушева Татьяна Александровна Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2791317B2 (ja) 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
US6881423B2 (en) 1996-02-27 2005-04-19 Teijin Limited Powdery composition for nasal administration
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
IT1286496B1 (it) 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
SE9604486D0 (sv) 1996-12-05 1996-12-05 Astra Ab Novel formulation
FR2756739B1 (fr) 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
JPH1121229A (ja) 1997-06-30 1999-01-26 Kyoto Yakuhin Kogyo Kk 抗真菌性外用製剤およびその製造方法
JP3386349B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 水性懸濁医薬品組成物
JPH11130658A (ja) 1997-10-30 1999-05-18 Teijin Ltd 水性懸濁医薬品組成物
JP3386348B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 鼻腔内投与用水性懸濁製剤
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
EP1050299A4 (de) 1998-01-22 2007-05-02 Santen Pharmaceutical Co Ltd Augentropfen aus fluorometholonsuspension
SE514128C2 (sv) 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6124268A (en) * 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
RU11829U1 (ru) 1999-05-05 1999-11-16 Специальное конструкторское бюро транспортного машиностроения (ОАО Спецмаш) Рабочая площадка для буровых установок
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
KR20010089887A (ko) 1999-10-20 2001-10-12 야스이 쇼사꾸 수성의약품 조성물
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida

Also Published As

Publication number Publication date
NO20021866L (no) 2002-04-19
DK1227817T3 (da) 2004-11-15
BRPI0014880B8 (pt) 2021-05-25
AU7953200A (en) 2001-04-30
PL356190A1 (en) 2004-06-14
HK1051003A1 (en) 2003-07-18
TWI269655B (en) 2007-01-01
IL148725A (en) 2006-12-31
HUP0203756A3 (en) 2004-06-28
CN1379673A (zh) 2002-11-13
ATE270107T1 (de) 2004-07-15
US20130095146A1 (en) 2013-04-18
ME00568A (en) 2011-12-20
MY121175A (en) 2005-12-30
SK6932002A3 (en) 2002-09-10
BR0014880A (pt) 2002-06-11
BRPI0014880B1 (pt) 2015-08-11
MXPA02003975A (es) 2003-09-25
CA2388325C (en) 2007-09-18
HUP0203756A2 (en) 2003-05-28
DE60011924T2 (de) 2005-07-07
NZ518299A (en) 2004-03-26
CO5251406A1 (es) 2003-02-28
EP1227817A1 (de) 2002-08-07
KR20020060205A (ko) 2002-07-16
CZ20021284A3 (cs) 2002-07-17
NO327379B1 (no) 2009-06-22
KR100705372B1 (ko) 2007-04-11
PL197537B1 (pl) 2008-04-30
ZA200203078B (en) 2003-01-29
ES2223595T3 (es) 2005-03-01
PT1227817E (pt) 2004-11-30
SI1227817T1 (en) 2004-12-31
RS50345B (sr) 2009-11-10
US8383611B1 (en) 2013-02-26
HRP20020345B1 (en) 2006-12-31
HU228894B1 (hu) 2013-06-28
JP2003512330A (ja) 2003-04-02
EP1227817B1 (de) 2004-06-30
NO20021866D0 (no) 2002-04-19
ME00568B (me) 2011-12-20
BG65799B1 (bg) 2009-12-31
JP4856338B2 (ja) 2012-01-18
CZ297780B6 (cs) 2007-03-28
SK286194B6 (sk) 2008-05-06
AR026073A1 (es) 2002-12-26
CN1198623C (zh) 2005-04-27
WO2001028563A1 (en) 2001-04-26
HRP20020345A2 (en) 2005-10-31
AU776587B2 (en) 2004-09-16
EA200200383A1 (ru) 2002-10-31
CA2388325A1 (en) 2001-04-26
BG106517A (en) 2002-12-29
IL148725A0 (en) 2002-09-12
TR200200831T2 (tr) 2002-07-22
EA005201B1 (ru) 2004-12-30
PE20010713A1 (es) 2001-07-13
YU28102A (sh) 2004-12-31

Similar Documents

Publication Publication Date Title
DE50104135D1 (de) Wässrige zusammensetzungen
AR023440A1 (es) Composiciones antitranspirantes
IS6120A (is) Lyfjablanda
ATE303787T1 (de) Schergelzusammensetzungen
NO20016115L (no) Substituerte heterosykelkondenserte gamma-karbolin
PT1224180E (pt) Azois substituidos
DE69920730D1 (de) Wässrige zusammensetzung
DE69937967D1 (de) Wässrige überzugszusammensetzungen
AR028197A1 (es) Composiciones antitranspirantes
ID29785A (id) Komposisi-komposisi sampo
PT1206182E (pt) Composicoes herbicidas
DE60007731D1 (de) Schweisshemmende zusammensetzungen
BR0013417B1 (pt) composiÇço aquosa.
EE200200150A (et) Preparaat
ATE369830T1 (de) Schweisshemmende zusammensetzungen
ATE314049T1 (de) Schweisshemmende zusammensetzungen
DE69943245D1 (de) Gaserzeugende zusammensetzung
ATE450652T1 (de) Wässrige zusammensetzung
DE60011924D1 (de) Ciclesonidhaltige wässrige arzneizusammensetzungen
BR0113783B1 (pt) Composição aquosa
DE60020682D1 (de) Resorcinenthaltende zusammensetzung
ATE253822T1 (de) Wachstumsregulierende wässrige zusammensetzungen
DE60005826D1 (de) Fungizide zusammensetzungen
NO20022927D0 (no) Substituerte pyrrazoler
ID27329A (id) Komposisi penghambat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NYCOMED GMBH, 78467 KONSTANZ, DE